TITLE

Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease

AUTHOR(S)
Calverley, P. M. A.
PUB. DATE
January 1999
SOURCE
Thorax;Jan1999, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66877016

 

Related Articles

  • Inhaled corticosteroids worth it in patients with severe COPD.  // PharmacoEconomics & Outcomes News;5/8/2004, Issue 452, p9 

    Deals with the findings of a study regarding the use of inhaled corticosteroids among patients with chronic obstructive pulmonary disease. Cost effectiveness of inhaled corticosteroids; Mortality benefit of inhaled corticosteroids.

  • Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Sutherland, E. Rand; Highland, Kristin B. // Annals of Internal Medicine;11/18/2003, Vol. 139 Issue 10, p864 

    Presents a letter to the editor which focuses on the importance of inhaled corticosteroids in treatment of chronic obstructive pulmonary disease.

  • Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Internal Medicine Alert;3/29/2010, Vol. 32 Issue 6, p48 

    The article reports on the effectiveness of inhaled corticosteroids (ICS) in treating acute exacerbations of chronic obstructive pulmonary disease (AC-COPD).

  • COPD and osteoporosis risk in men. Lucas, Beverly D. // Patient Care;1/15/1999, Vol. 33 Issue 1, p29 

    Reports that chronic obstructive pulmonary disease is an independent risk factor for the development of osteoporosis in men. Comparison of inhaled versus oral corticosteroids.

  • Inhaled corticosteroids and mortality in COPD. Sin, D. D. // Thorax;Oct2006, Vol. 61 Issue 10, p918 

    A letter to the editor is presented responding to a letter in the August 2006 issue of "Thorax" on inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.

  • Inhaled corticosteroids and mortality in COPD. Sin, D. D. // Thorax;Oct2006, Vol. 61 Issue 10, p918 

    A letter to the editor is presented responding to a letter in the August 2006 issue of "Thorax" on the role of inhaled corticosteroids in chronic obstructive pulmonary disease.

  • Q/What are the benefits and risks of inhaled corticosteroids for COPD? Hamilton, Tanya; Miller, John B.; Vincent, E. Chris; St. Anna, Leilani; Guthmann, Richard // Journal of Family Practice;May2014, Vol. 63 Issue 5, p276 

    The article provides an answer to a question regarding the benefits and risks of inhaled corticosteroids for chronic obstructive pulmonary disease (COPD).

  • Inhaled Steroids Increase Risk of TB in COPD Patients.  // Clinical Cardiology Alert;Jun2013 Clinical Briefs in Primary Care, p12 

    The article focuses on inhaled corticosteroids (ICS) were the use of these steroids leads to increase the risk of pulmonary tuberculosis (TB) in patients with chronic obstructive pulmonary disease (COPD).

  • Treating COPD in the RealWorld. Calverley, Peter M. A. // JAMA: Journal of the American Medical Association;9/17/2014, Vol. 312 Issue 11, p1101 

    An introduction to a study about the efficacy of using long-acting beta-agonists (LABA) alone or in combination with inhaled corticosteroids (ICS) in the treatment of chronic obstructive pulmonary disease (COPD) in elderly patients is presented.

  • Inhaled Corticosteroids in Moderate to Severe COPD. Miller, Karl E. // American Family Physician;1/1/2005, Vol. 71 Issue 1, p174 

    Explains a study which reviewed the effectiveness of four strategies for the use of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease (COPD). Forecast on COPD-related morbidity and mortality; Impact of inhaled corticosteroids.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics